BACKGROUND. The most common serious complication of blood transfusion is post-transfusion hepatitis from the hepatitis C virus (HCV). Blood banks now screen blood donors for surrogate markers of non-A, non-B hepatitis and antibodies to HCV, but the current risk of post-transfusion hepatitis C is unknown. METHODS. From 1985 through 1991, blood samples and medical information were obtained prospectively from patients before and at least six months after cardiac surgery. The stored serum samples were tested for antibodies to HCV by enzyme immunoassay, and by recombinant immunoblotting if positive. RESULTS. Of the 912 patients who received transfusions before donors were screened for surrogate markers, 35 seroconverted to HCV, for a risk of 3.84 percent per patient (0.45 percent per unit transfused). For the 976 patients who received transfusions after October 1986 with blood screened for surrogate markers, the risk of seroconversion was 1.54 percent per patient (0.19 percent per unit). For the 522 patients receiving transfusions since the addition in May 1990 of screening for antibodies to HCV, the risk was 0.57 percent per patient (0.03 percent per unit). The trend toward decreasing risk with increasingly stringent screening of donors was statistically significant (P less than 0.001). After we controlled for the method of donor screening, the risk of seroconversion was strongly associated (P less than 0.001) with the volume of blood transfused, but not with the use of particular blood components. CONCLUSIONS. The incidence of post-transfusion hepatitis C has decreased markedly since the implementation of donor screening for surrogate markers and antibodies to HCV. The current risk of post-transfusion hepatitis is about 3 per 10,000 units transfused.
Source Information
Department of Epidemiology, Johns Hopkins School of Hygiene and Public Health, Baltimore, MD 21205.
This article has been cited by other articles:
Cagle, H. H, Jacob, J., Homan, C. E., Williams, J. L., Christensen, C. J., McMahon, B. J.
(2007). Results of a General Hepatitis C Lookback Program for Persons Who Received Blood Transfusions in a Neonatal Intensive Care Unit Between January 1975 and July 1992. Arch Pediatr Adolesc Med
161: 125-130
[Abstract][Full Text]
Jimenez-Hernandez, N., Torres-Puente, M., Bracho, M. A., Garcia-Robles, I., Ortega, E., del Olmo, J., Carnicer, F., Gonzalez-Candelas, F., Moya, A.
(2007). Epidemic dynamics of two coexisting hepatitis C virus subtypes. J. Gen. Virol.
88: 123-133
[Abstract][Full Text]
JITTIWUTIKARN, J., THONGSAWAT, S., SURIYANON, V., MANEEKARN, N., CELENTANO, D., RAZAK, M. H., SRIRAK, N., VONGCHAK, T., KAWICHAI, S., THOMAS, D., SRIPAIPAN, T., NETSKI, D., ANANTHAKRISHNAN, A., NELSON, K. E.
(2006). HEPATITIS C INFECTION AMONG DRUG USERS IN NORTHERN THAILAND. Am J Trop Med Hyg
74: 1111-1116
[Abstract][Full Text]
Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., Alter, M. J.
(2006). The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002. ANN INTERN MED
144: 705-714
[Abstract][Full Text]
Wong, T., Lee, S. S.
(2006). Hepatitis C: a review for primary care physicians. CMAJ
174: 649-659
[Abstract][Full Text]
Hutchinson, S J, Goldberg, D J, King, M, Cameron, S O, Shaw, L E, Brown, A, MacKenzie, J, Wilson, K, MacDonald, L
(2004). Hepatitis C virus among childbearing women in Scotland: prevalence, deprivation, and diagnosis. Gut
53: 593-598
[Abstract][Full Text]
Englert, Y., Lesage, B., Van Vooren, J.-P., Liesnard, C., Place, I., Vannin, A.-S., Emiliani, S., Delbaere, A.
(2004). Medically assisted reproduction in the presence of chronic viral diseases. Hum Reprod Update
10: 149-162
[Abstract][Full Text]
Henderson, D. K.
(2003). Managing Occupational Risks for Hepatitis C Transmission in the Health Care Setting. Clin. Microbiol. Rev.
16: 546-568
[Abstract][Full Text]
Choi, J. W.
(2003). Association Between Elevated Serum Hepatic Enzyme Activity and Total Body Fat in Obese Humans. Annals of Clinical & Laboratory Science
33: 257-264
[Abstract][Full Text]
MARX, M. A., MURUGAVEL, K. G., SIVARAM, S., BALAKRISHNAN, P., STEINHOFF, M., ANAND, S., THOMAS, D. L., SOLOMON, S., CELENTANO, D. D.
(2003). THE ASSOCIATION OF HEALTH-CARE USE AND HEPATITIS C VIRUS INFECTION IN A RANDOM SAMPLE OF URBAN SLUM COMMUNITY RESIDENTS IN SOUTHERN INDIA. Am J Trop Med Hyg
68: 258-262
[Abstract][Full Text]
Salomon, J. A., Weinstein, M. C., Hammitt, J. K., Goldie, S. J.
(2002). Empirically Calibrated Model of Hepatitis C Virus Infection in the United States. Am J Epidemiol
156: 761-773
[Abstract][Full Text]
Icardi, G., Ansaldi, F., Bruzzone, B. M., Durando, P., Lee, S., de Luigi, C., Crovari, P.
(2001). Novel Approach To Reduce the Hepatitis C Virus (HCV) Window Period: Clinical Evaluation of a New Enzyme-Linked Immunosorbent Assay for HCV Core Antigen. J. Clin. Microbiol.
39: 3110-3114
[Abstract][Full Text]
Hyams, K. C., Riddle, J., Rubertone, M., Trump, D., Alter, M. J., Cruess, D. F., Han, X., Nainam, O. V., Seeff, L. B., Mazzuchi, J. F., Bailey, S.
(2001). Prevalence and Incidence of Hepatitis C Virus Infection in the US Military: A Seroepidemiologic Survey of 21,000 Troops. Am J Epidemiol
153: 764-770
[Abstract][Full Text]
Ness, P. M.
(2000). Transfusion Medicine: An Overview and Update. Clin. Chem.
46: 1270-1276
[Abstract][Full Text]
Strickland, D. K., Riely, C. A., Patrick, C. C., Jones-Wallace, D., Boyett, J. M., Waters, B., Fleckenstein, J. F., Dean, P. J., Davila, R., Caver, T. E., Hudson, M. M.
(2000). Hepatitis C infection among survivors of childhood cancer. Blood
95: 3065-3070
[Abstract][Full Text]
Burns, D. N., Minkoff, H.
(1999). HEPATITIS C: SCREENING IN PREGNANCY. Obstet Gynecol
94: 1044-1048
[Abstract][Full Text]
Kenny-Walsh, E., The Irish Hepatology Research Group,
(1999). Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin. NEJM
340: 1228-1233
[Abstract][Full Text]
Stensrud, P. E., Nuttall, G. A., de Castro, M. A., Abel, M. D., Ereth, M. H., Oliver, W. C. Jr, Bryant, S. C., Schaff, H. V.
(1999). A prospective, randomized study of cardiopulmonary bypass temperature and blood transfusion. Ann. Thorac. Surg.
67: 711-715
[Abstract][Full Text]
Prati, D., Lin, Y.-H., De Mattei, C., Liu, J.-K., Farma, E., Ramaswamy, L., Zanella, A., Lee, H., Rebulla, P., Allain, J.-P., Sirchia, G., Chen, B.
(1999). A Prospective Study on TT Virus Infection in Transfusion-Dependent Patients With beta -Thalassemia. Blood
93: 1502-1505
[Abstract][Full Text]
Prati, D., Zanella, A., Farma, E., De Mattei, C., Bosoni, P., Zappa, M., Picone, A., Mozzi, F., Rebulla, P., Cappellini, M. D., Allain, J.-P., Sirchia, G.
(1998). A Multicenter Prospective Study on the Risk of Acquiring Liver Disease in Anti-Hepatitis C Virus Negative Patients Affected From Homozygous beta -Thalassemia. Blood
92: 3460-3464
[Abstract][Full Text]
Spiess, B. D., Ley, C., Body, S. C., Siegel, L. C., Stover, E. P., Maddi, R., D'Ambra, M., Jain, U., Liu, F., Herskowitz, A., Mangano, D. T., Levin, J.
(1998). Hematocrit value on intensive care unit entry influences thefrequency of q-wave myocardial infarction after coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg.
116: 460-464
[Abstract][Full Text]
SUNYER, J., ANTO, J. M., MCFARLANE, D., DOMINGO, A., TOBIAS, A., BARCELO, M.-A., MUNOZ, A.
(1998). Sex Differences in Mortality of People Who Visited Emergency Rooms for Asthma and Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med.
158: 851-856
[Abstract][Full Text]
KEATING, E. M.
(1998). Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Current Options and Approaches for Blood Management in Orthopaedic Surgery*{{dagger}}. JBJS
80: 750-62
[Full Text]
Committee on Infectious Diseases,
(1998). Hepatitis C Virus Infection. Pediatrics
101: 481-485
[Abstract][Full Text]
Wiklund, R. A., Rosenbaum, S. H.
(1997). Anesthesiology- First of Two Parts. NEJM
337: 1132-1141
[Full Text]
Tobler, L. H., Busch, M. P.
(1997). History of posttransfusion hepatitis. Clin. Chem.
43: 1487-1493
[Abstract][Full Text]
Cesaro, S., Petris, M. G., Rossetti, F., Cusinato, R., Pipan, C., Guido, M., Masiero, L., Botta, G. A., Meloni, G. A., Zanesco, L.
(1997). Chronic Hepatitis C Virus Infection After Treatment for Pediatric Malignancy. Blood
90: 1315-1320
[Abstract][Full Text]
Courouce, A.-M., Pillonel, J., The Retrovirus and Viral Hepatitis Working Groups, , Schreiber, G. B., Busch, M. P., Kleinman, S. H.
(1996). Transfusion-Transmitted Viral Infections. NEJM
335: 1609-1610
[Full Text]
Holland, P. V.
(1996). Viral Infections and the Blood Supply. NEJM
334: 1734-1735
[Full Text]
Masuko, K., Mitsui, T., Iwano, K., Yamazaki, C., Okuda, K., Meguro, T., Murayama, N., Inoue, T., Tsuda, F., Okamoto, H., Miyakawa, Y., Mayumi, M.
(1996). Infection with Hepatitis GB Virus C in Patients on Maintenance Hemodialysis. NEJM
334: 1485-1491
[Abstract][Full Text]
Allison, M. C, Mills, P. R
(1996). Controversies in Management: Screening asymptomatic people at high risk for hepatitis C: The case against. BMJ
312: 1349-1350
[Full Text]
Esteban, J. I., Gomez, J., Martell, M., Cabot, B., Quer, J., Camps, J., Gonzalez, A., Otero, T., Moya, A., Esteban, R., Guardia, J.
(1996). Transmission of Hepatitis C Virus by a Cardiac Surgeon. NEJM
334: 555-561
[Abstract][Full Text]
McNair, A N B, Tibbs, C J, Williams, R
(1995). Recent Advances: Hepatology. BMJ
311: 1351-1355
[Full Text]
Levy, J. H., Pifarre, R., Schaff, H. V., Horrow, J. C., Albus, R., Spiess, B., Rosengart, T. K., Murray, J., Clark, R. E., Smith, P., Nadel, A., Bonney, S. L., Kleinfield, R.
(1995). A Multicenter, Double-Blind, Placebo-Controlled Trial of Aprotinin for Reducing Blood Loss and the Requirement for Donor-Blood Transfusion in Patients Undergoing Repeat Coronary Artery Bypass Grafting. Circulation
92: 2236-2244
[Abstract][Full Text]
Mele, A., Stroffolini, T., Catapano, R., Palumbo, F., Moiraghi, A., Novaco, F.
(1995). Incidence of transfusion associated B and non-A, non-B hepatitis in Italy. BMJ
311: 846-847
[Full Text]
Etchason, J., Petz, L., Keeler, E., Calhoun, L., Kleinman, S., Snider, C., Fink, A., Brook, R.
(1995). The Cost Effectiveness of Preoperative Autologous Blood Donations. NEJM
332: 719-724
[Abstract][Full Text]
Rutherford, C. J., Kaplan, H. S.
(1995). Autologous Blood Donation -- Can We Bank on It?. NEJM
332: 740-742
[Full Text]
Goodnough, L. T., Bodner, M. S., Martin, J. W.
(1994). Blood Transfusion and Blood Conservation: Cost and Utilization Issues. American Journal of Medical Quality
9: 172-183
[Abstract]
The EPIC Investigators,
(1994). Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty. NEJM
330: 956-961
[Abstract][Full Text]
Blajchman, M.A., Feinman, S.V., Bull, S.B., Nelson, K. E., Ahmed, F., Ness, P., Donahue, J. G., Dodd, R. Y.
(1993). The Incidence of Post-Transfusion Hepatitis. NEJM
328: 1280-1281
[Full Text]
